Literature DB >> 6165428

Toxicity of interferon.

G M Scott, D S Secher, D Flowers, J Bate, K Cantell, D A Tyrrell.   

Abstract

The effects of partially purified human leucocyte interferon (PIF) and of a preparation purified by passage twice through a monoclonal antibody affinity chromatography column (NK21F) were compared with those of a control solution in healhty volunteers. After intramuscular injections both interferon preparations caused rises in pulse rate and body temperature, changes in circulating white cell counts, and various unpleasant symptoms, the most common of which were headache, malaise, and fever. Slightly lower doses of NK21F were given, and this was reflected in lower peak serum concentrations. Mean symptom scores, however, were not lower after NK21F than after PIF. Local inflammatory reactions eight hours after intradermal inoculations of these interferons were similar. Purification of interferon using a monoclonal antibody does not reduce the facets of its activity considered in this study. They are therefore inherent in the leucocyte interferon type selected by the antibody.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165428      PMCID: PMC1504978          DOI: 10.1136/bmj.282.6273.1345

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  10 in total

1.  Le interferon production by human fibroblasts.

Authors:  T G Hayes; Y K Yip; J Vilcek
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

2.  Large-scale production of human leukocyte interferon containing 10(8) units per ml.

Authors:  K Cantell; S Hirvonen
Journal:  J Gen Virol       Date:  1978-06       Impact factor: 3.891

Review 3.  Interferon: therapeutic fact or fiction for the '80s?

Authors:  G M Scott; D A Tyrrell
Journal:  Br Med J       Date:  1980-06-28

4.  A monoclonal antibody for large-scale purification of human leukocyte interferon.

Authors:  D S Secher; D C Burke
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

Review 5.  Does interferon cure cancer?

Authors:  K Sikora
Journal:  Br Med J       Date:  1980-09-27

6.  Skin reactions to interferon inoculations are reduced but not abolished by purification.

Authors:  G M Scott; W E Stewart; D A Tyrrell; K Cantell; T Cartwright; V G Edy
Journal:  J Interferon Res       Date:  1980

7.  Interferon fever.

Authors:  M Karmazyn; D F Horrobin; M S Manku; R A Karmali; R O Morgan; A I Ally; S C Cunnane
Journal:  Lancet       Date:  1977-08-06       Impact factor: 79.321

8.  Interferon induction by viruses and polynucleotides: a differential effect of comptothecin.

Authors:  K T Atherton; D C Burke
Journal:  J Gen Virol       Date:  1975-12       Impact factor: 3.891

9.  Side effects of long-term treatment with human leukocyte interferon.

Authors:  S Ingimarsson; K Cantell; H Strander
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

10.  Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease.

Authors:  T J Priestman
Journal:  Lancet       Date:  1980-07-19       Impact factor: 79.321

  10 in total
  29 in total

1.  Surveillance of respiratory viral infections by rapid immunofluorescence diagnosis, with emphasis on virus interference.

Authors:  G Anestad
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

Review 2.  Cold comfort for the catarrhal child.

Authors:  D Isaacs
Journal:  Arch Dis Child       Date:  1990-12       Impact factor: 3.791

3.  A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer.

Authors:  K Sriskandan; P Garner; J Watkinson; K W Pettingale; D Brinkley; F M Calman; D E Tee
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 4.  Interferons, a group of multiple lymphokines.

Authors:  H Kirchner
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Pilot study of recombinant interferon alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus.

Authors:  J Portnoy; R Hicks; F Pacheco; L Olson
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

6.  Receptor mediated pathways for interferon action: in vivo implications.

Authors:  K E Mogensen; M T Bandu; F Vignaux; G Uze; P Eid
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

7.  Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies.

Authors:  T H Bacon; A de Vere-Tyndall; D A Tyrrell; A M Denman; B M Ansell
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

8.  Human leukocyte interferon-alpha in cream, for the treatment of genital warts in Asian women: a placebo-controlled, double-blind study.

Authors:  T A Syed; S Lundin; K M Cheema; B M Kahlon; R Cheema; S A Ahmad; M Ahmad
Journal:  Clin Investig       Date:  1994-11

Review 9.  Preclinical safety testing of species-specific proteins produced with recombinant DNA-techniques. An attempt to transfer current experience into future testing strategies.

Authors:  K Teelmann; C Hohbach; H Lehmann
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153

10.  Diazepam ablates the constitutional side-effects of gamma interferon.

Authors:  G J Beattie; J F Smyth
Journal:  Med Oncol Tumor Pharmacother       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.